|
Beclomethasone (BDP group) (N = 110)
|
Salbutamol (Placebo group) (N = 56)
|
---|
Male, n (%)
|
64 (58.2)
|
34 (60.7)
|
Risk factors for asthma, n (%)
|
57 (51.8)
|
30 (53.6)
|
Age, yr
|
2.35 ± 0.81
|
2.29 ± 0.78
|
Weight, kg
|
15.4 ± 2.82
|
14.9 ± 2.74
|
Height, cm
|
97.5 ± 9.19
|
96.0 ± 9.61
|
Duration of wheezing, yr
|
1.59 ± 0.87
|
1.43 ± 0.82
|
Symptom-free days, %
|
21.4 ± 18.3
|
25.9 ± 21.0
|
Daily coughing score
|
1.43 ± 0.71
|
1.35 ± 0.80
|
Daily Salbutamol use, na
|
0.49 ± 0.48
|
0.42 ± 0.35
|
- Values of symptom-free days, daily coughing score and daily salbutamol use are mean of the 2-week run-in period ± SD. Beclomethasone = beclomethasone dipropionate; a number of nebulizations per day.